Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats
Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous system (CNS) in young adults. Chronic treatments with histone deacetylase inhibitors (HDACis) have been reported to ameliorate experimental autoimmune encephalomyelitis (EAE), a rodent model...
Main Authors: | Gonçalo Castelo-Branco, Pernilla Stridh, André Ortlieb Guerreiro-Cacais, Milena Z. Adzemovic, Ana Mendanha Falcão, Monica Marta, Rasmus Berglund, Alan Gillett, Kedir Hussen Hamza, Hans Lassmann, Ola Hermanson, Maja Jagodic |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-11-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996114002502 |
Similar Items
-
Acute Disseminated Encephalomyelitis with Measles
by: Ishrat Jahan, et al.
Published: (2013-01-01) -
Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment
by: Sundararajan Jayaraman, et al.
Published: (2022-10-01) -
A Case of Measles with Encephalomyelitis
by: Ali Irfan Baran, et al.
Published: (2020-09-01) -
The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34
by: Rasmus Berglund, et al.
Published: (2024-01-01) -
Avian encephalomyelitis virus in backyard chickens
by: Abdullah I. A. Al-Mubarak, et al.
Published: (2023-09-01)